MX2018014124A - Aposito para heridas o para la piel. - Google Patents

Aposito para heridas o para la piel.

Info

Publication number
MX2018014124A
MX2018014124A MX2018014124A MX2018014124A MX2018014124A MX 2018014124 A MX2018014124 A MX 2018014124A MX 2018014124 A MX2018014124 A MX 2018014124A MX 2018014124 A MX2018014124 A MX 2018014124A MX 2018014124 A MX2018014124 A MX 2018014124A
Authority
MX
Mexico
Prior art keywords
wound dressing
dermal patch
acid
pharmaceutical composition
prodrug
Prior art date
Application number
MX2018014124A
Other languages
English (en)
Inventor
Schulze Christian
Arshi Annahit
Hemmrich Karsten
Original Assignee
Bsn Medical Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bsn Medical Gmbh filed Critical Bsn Medical Gmbh
Publication of MX2018014124A publication Critical patent/MX2018014124A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/26—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/114—Nitric oxide, i.e. NO
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/606—Coatings
    • A61L2300/608—Coatings having two or more layers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)

Abstract

La presente invención se refiere a una composición farmacéutica y a este respecto en particular a un apósito para la piel o para heridas, que comprende un oligómero y/o un polímero que hidrolizan de manera ácida y un profármaco que puede activarse con ácido, de modo que en la composición farmacéutica o bien en el apósito para la piel o para heridas se forma el principio activo mediante acción de ácidos a partir del profármaco. La invención se refiere además a un correspondiente procedimiento para la liberación de principios activos de una composición farmacéutica.
MX2018014124A 2016-05-17 2017-05-15 Aposito para heridas o para la piel. MX2018014124A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16169905.3A EP3246050A1 (de) 2016-05-17 2016-05-17 Wund- oder hautauflage
PCT/EP2017/061587 WO2017198603A1 (de) 2016-05-17 2017-05-15 Wund- oder hautauflage

Publications (1)

Publication Number Publication Date
MX2018014124A true MX2018014124A (es) 2019-07-04

Family

ID=56068693

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018014124A MX2018014124A (es) 2016-05-17 2017-05-15 Aposito para heridas o para la piel.

Country Status (9)

Country Link
US (1) US11389559B2 (es)
EP (2) EP3246050A1 (es)
CN (1) CN109152860B (es)
AU (1) AU2017267176B2 (es)
BR (1) BR112018073703B1 (es)
CO (1) CO2018012346A2 (es)
MX (1) MX2018014124A (es)
WO (1) WO2017198603A1 (es)
ZA (1) ZA201808318B (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0808376D0 (en) 2008-05-08 2008-06-18 Bristol Myers Squibb Co Wound dressing
GB0817796D0 (en) 2008-09-29 2008-11-05 Convatec Inc wound dressing
GB201020236D0 (en) 2010-11-30 2011-01-12 Convatec Technologies Inc A composition for detecting biofilms on viable tissues
ES2748519T3 (es) 2010-12-08 2020-03-17 Convatec Technologies Inc Accesorio de sistema de exudado de heridas
JP5965409B2 (ja) 2010-12-08 2016-08-03 コンバテック・テクノロジーズ・インコーポレイテッドＣｏｎｖａｔｅｃ Ｔｅｃｈｎｏｌｏｇｉｅｓ Ｉｎｃ 創傷滲出液を評価するための統合システム
GB201115182D0 (en) 2011-09-02 2011-10-19 Trio Healthcare Ltd Skin contact material
GB2497406A (en) 2011-11-29 2013-06-12 Webtec Converting Llc Dressing with a perforated binder layer
EP2935688A2 (en) 2012-12-20 2015-10-28 ConvaTec Technologies Inc. Processing of chemically modified cellulosic fibres
CN108697649A (zh) 2015-12-08 2018-10-23 林德拉有限公司 用于胃驻留系统的几何构型
KR20190013725A (ko) 2016-03-30 2019-02-11 컨바텍 테크놀러지스 인크 상처 내의 미생물 감염의 검출
US20230213525A1 (en) 2016-03-30 2023-07-06 Qualizyme Diagnostics Gmbh & Co Kg Detecting microbial infection in wounds
EP3463313A4 (en) * 2016-05-27 2019-12-18 Lyndra, Inc. MATERIAL ARCHITECTURE FOR GASTRIC STAY SYSTEMS
US11266774B2 (en) 2016-07-08 2022-03-08 Convatec Technologies Inc. Fluid collection apparatus
KR20190026858A (ko) 2016-07-08 2019-03-13 컨바텍 테크놀러지스 인크 가요성 부압 시스템
CN109689005B (zh) 2016-07-08 2022-03-04 康沃特克科技公司 流体流量感测
CN110996906A (zh) 2017-06-09 2020-04-10 林德拉有限公司 具有调节释放速度的膜的胃驻留系统
CA3074680A1 (en) * 2017-09-05 2019-03-14 Breathevision Ltd. Monitoring system
US11506658B2 (en) 2019-04-24 2022-11-22 Progenitec, Inc. System for analysis of body fluids and wound-associated biomolecules
US11771819B2 (en) 2019-12-27 2023-10-03 Convatec Limited Low profile filter devices suitable for use in negative pressure wound therapy systems
US11331221B2 (en) 2019-12-27 2022-05-17 Convatec Limited Negative pressure wound dressing
CN113018518B (zh) * 2021-03-05 2022-06-03 上海交通大学医学院附属新华医院 一种用于婴幼儿狭窄血管可吸收血管支架涂层的制备方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4757128A (en) 1986-08-01 1988-07-12 Massachusetts Institute Of Technology High molecular weight polyanhydride and preparation thereof
US4888176A (en) 1984-05-21 1989-12-19 Massachusetts Institute Of Technology Controlled drug delivery high molecular weight polyanhydrides
US4857311A (en) 1987-07-31 1989-08-15 Massachusetts Institute Of Technology Polyanhydrides with improved hydrolytic degradation properties
US4997904A (en) 1989-08-25 1991-03-05 Nova Pharmaceutical Corporation Aromatic polyanhydride compositions
JP3740549B2 (ja) 1990-03-30 2006-02-01 アルザ・コーポレーション イオン侵透療法による薬剤投与の装置と方法
US5264540A (en) 1992-07-20 1993-11-23 Ethicon, Inc. Aromatic polyanhydrides
US5405919A (en) 1992-08-24 1995-04-11 The United States Of America As Represented By The Secretary Of Health And Human Services Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions and methods of treating biological disorders
US5519020A (en) * 1994-10-28 1996-05-21 The University Of Akron Polymeric wound healing accelerators
DK174312B1 (da) 1996-06-06 2002-12-02 Ole Pedersen Fremgangsmåde til måling af strømningshastighed og diffusivitet, mikrosensor til brug ved fremgangsmåden samt anvendelse af sådan mikrosensor
US5994444A (en) * 1997-10-16 1999-11-30 Medtronic, Inc. Polymeric material that releases nitric oxide
US6706274B2 (en) * 2001-01-18 2004-03-16 Scimed Life Systems, Inc. Differential delivery of nitric oxide
WO2003006427A1 (en) 2001-07-12 2003-01-23 Johns Hopkins University Compounds that release nitric oxide at controlled rates upon photolysis
US6673338B1 (en) 2001-09-10 2004-01-06 The United States Of America As Represented By The Department Of Health And Human Services Nitric oxide-releasing imidate and thioimidate diazeniumdiolates, compositions, uses thereof and method of making same
US20030039697A1 (en) 2002-09-12 2003-02-27 Yi-Ju Zhao Matrices containing nitric oxide donors and reducing agents and their use
JP2007526911A (ja) * 2004-01-22 2007-09-20 ザ ユニバーシティ オブ アクロン 医療装置および治療のためのポリマーｎｏ供与体プレドラッグナノファイバコーティング
CA2588744A1 (en) 2004-11-29 2006-06-01 The University Of Akron Topical nitric oxide donor devices and methods for their therapeutic use
US8071083B2 (en) * 2004-12-13 2011-12-06 Progentix Orthobiology B.V. Tissue regeneration
GB0505035D0 (en) * 2005-03-11 2005-04-20 Insense Ltd Improvements relating to skin dressings
CN1990045B (zh) * 2005-12-30 2010-12-22 北京尼奥克斯生物科技有限公司 一种新型高效烧烫伤类贴剂及其制备方法
WO2008012845A1 (en) 2006-07-26 2008-01-31 Stmicroelectronics S.R.L. Use of nitroaniline derivatives for the production of nitric oxide
GB0715556D0 (en) * 2007-08-09 2007-09-19 Insense Ltd Improvements relating to skin dressings
AU2008315318B2 (en) 2007-10-26 2014-02-06 National Institute Of Immunology Biodegradable polymer scaffold and process for preparation thereof
US20110106000A1 (en) 2008-06-24 2011-05-05 Micropharma Limited Nitric Oxide Compositions and Devices and Methods for Cosmesis
US9566372B2 (en) * 2012-09-28 2017-02-14 The Regents Of The University Of Michigan Sustained nitric oxide release coating using diazeniumdiolate-doped polymer matrix with ester capped poly(lactic-co-glycolic acid) additive
WO2016115448A1 (en) * 2015-01-15 2016-07-21 Marshall University Research Corporation Wound coverings comprising vitamin d and related methods

Also Published As

Publication number Publication date
BR112018073703A2 (pt) 2019-02-26
AU2017267176A1 (en) 2019-01-17
CO2018012346A2 (es) 2019-10-31
US20190290799A1 (en) 2019-09-26
WO2017198603A1 (de) 2017-11-23
US11389559B2 (en) 2022-07-19
CN109152860A (zh) 2019-01-04
AU2017267176B2 (en) 2021-05-27
ZA201808318B (en) 2019-08-28
CN109152860B (zh) 2022-04-05
EP3458115B1 (de) 2020-08-26
EP3246050A1 (de) 2017-11-22
BR112018073703B1 (pt) 2022-04-26
EP3458115A1 (de) 2019-03-27

Similar Documents

Publication Publication Date Title
MX2018014124A (es) Aposito para heridas o para la piel.
IL264413B (en) Preparations containing fibers obtained electrohydrodynamically for delivering specific doses of active substance to the skin or mucous membrane
ZA201708692B (en) Antibacterial compounds
WO2016137235A3 (ko) 마이크로 rna를 유효 성분으로 포함하는 암 치료용 약학 조성물
EP4289910A3 (en) Methods and compositions for wound healing
PH12016500649A1 (en) Combinations of histone deactylase inhibitors and immunomodulatory drugs
MX2022014634A (es) Metodos para la administracion linfatica de agentes activos.
MX2016011744A (es) Soluciones de buprenorfina de liberacion sostenida.
EP3151923A4 (en) Clear compositions and methods for the delivery of active ingredients for skin care
CY1124041T1 (el) Συνθεσεις που περιλαμβανουν κυκλοσπορινη
AR104562A1 (es) Tratamiento de madera que provee estabilidad dimensional
TR201900844T4 (tr) Tgf-r sinyal inhibitörleri olarak antisens oligonükleotidler.
EP3257508A4 (en) Application of chlorogenic acid in preparing medicines for treating melanoma and medicines for treating melanoma
MY193312A (en) Topical formulation for promoting wound healing
MA40473A (fr) Dispositifs d'administration de médicaments à base d'une silicone catalysée par du platine, et leurs procédés d'utilisation
EP3582813A4 (en) TREATMENT OF SUPPURATIVE HIDRADENITIS
PH12016502544B1 (en) Pharmaceutical preparation containing entecavir as active ingredient, and preparation method therefor
CL2018002128A1 (es) Composiciones y métodos para el tratamiento de heridas crónicas
EP3538116A4 (en) MICRO NEEDLE-BASED TRANSDERMAL DELIVERY SYSTEM AND METHOD FOR PRODUCING THE SAME
IN2014MU00916A (es)
EA201890419A1 (ru) ОТСЕЛЕКТИРОВАННЫЙ АМИД γ-ГИДРОКСИМАСЛЯНОЙ КИСЛОТЫ И ЕГО ПРИМЕНЕНИЯ ПРИ ЛЕЧЕНИИ ЗЛОУПОТРЕБЛЕНИЯ АЛКОГОЛЕМ
EP3277269A4 (en) Methods for prevention and treatment of cardiometabolic syndrome and compositions used therein
EP3688192C0 (en) MOLECULAR SIGNATURES OF THREE SUBPULATIONS OF DERMAL FIBROBLASTS AND DERMAL EQUIVALENT COMPRISING ONE OF THESE SUBPULATIONS
WO2016069542A3 (en) Lactone compounds and methods of making and using same
EP3360581A4 (en) PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF CANCER WITH INHIBITOR OF PLRG1 (PLEIOTROPER REGULATOR 1) AS AN ACTIVE SUBSTANCE